Inspired to transform the lives of people with neurological diseases, Novartis applies leading science and diverse platforms—like gene, cell, and RNA therapies—to tackle the root causes of neurodegeneration, neuromuscular, and neuroinflammatory neuroimmunology disorders. Our robust pipeline targets key areas such as multiple sclerosis, Alzheimer’s, and rare neuromuscular diseases. We partner with innovators worldwide, offering deep expertise and resources to accelerate impactful solutions for patients.